Oxytocin plays an important role in the regulation of normal cognitive func
tions and behaviors, which are disturbed in schizophrenia. Several, studies
suggest that oxytocinergic function is abnormal in schizophrenia patients.
Thus, oxytocin may be involved in the pathophysiology associated with this
disorder. This study investigated the regulatory effects of oxytocin on de
ficits in prepulse inhibition (PPI) associated with schizophrenia. Prepulse
inhibition (PPH) is an operational measure of sensorimotor gating which ca
n be measured across many species. PPI is the normal suppression of the sta
rtle reflex when the intense startling stimulus ("pulse") is immediately pr
eceded by a weaker stimulus ("prepulse"). Subcutaneously administered oxyto
cin (0.04-1.0 mg/kg) dose-dependently restored PPI that had been reduced in
rats by dizocilpine, a non-competitive NMDA antagonist, and by amphetamine
, an indirect dopamine agonist. Oxytocin did not produce a significant effe
ct on baseline PPI or PPI decreased by the direct dopamine agonist, apomorp
hine. The underlying startle response amplitude was also not significantly
altered by oxytocin. These results suggest that oxytocin may play an import
ant role in the modulation of dopaminergic and glutamatergic regulation of
PPI, and that it may act as a novel endogenous antipsychotic.